NasdaqGS - Delayed Quote USD
Ultragenyx Pharmaceutical Inc. (RARE)
34.03
-1.00
(-2.85%)
At close: May 30 at 4:00:01 PM EDT
34.00
-0.03
(-0.09%)
After hours: May 30 at 7:34:32 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 420,727 | 19 |
| Sales | 182,299 | 12 |
| Net Shares Purchased (Sold) | 238,428 | 31 |
| Total Insider Shares Held | 3.27M | -- |
| % Net Shares Purchased (Sold) | 7.90% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| DUNSIRE DEBORAH Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 15, 2025 |
| NARACHI MICHAEL A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 15, 2025 |
| SULIMAN SHEHNAAZ Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 15, 2025 |
| SANDERS CORAZON CORSEE D Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 15, 2025 |
| RAY AMRIT Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 15, 2025 |
| FUST MATTHEW K. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 15, 2025 |
| WELCH DANIEL G Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 15, 2025 |
| CROMBEZ ERIC M.D. Officer | Sale at price 35.11 - 39.24 per share. | Direct | 28,901 | May 5, 2025 |
| HORN HOWARD Chief Financial Officer | Sale at price 40.40 per share. | Direct | 72,114 | Mar 6, 2025 |
| PARSCHAUER KARAH HERDMAN Officer | Sale at price 42.10 per share. | Direct | 540,817 | Mar 3, 2025 |
| HARRIS ERIK Officer | Sale at price 42.10 per share. | Direct | 635,836 | Mar 3, 2025 |
| HUIZENGA THEODORE ALAN Officer | Sale at price 42.10 per share. | Direct | 40,711 | Mar 3, 2025 |
| PINION JOHN RICHARD Officer | Sale at price 42.10 per share. | Direct | 607,882 | Mar 3, 2025 |
| CROMBEZ ERIC M.D. Officer | Sale at price 42.10 per share. | Direct | 376,584 | Mar 3, 2025 |
| KAKKIS EMIL D Chief Executive Officer | Sale at price 42.10 - 42.48 per share. | Indirect | 4,153,571 | Mar 3, 2025 |
| KASSBERG THOMAS RICHARD Chairman of the Board | Sale at price 42.10 per share. | Direct | 253,779 | Mar 3, 2025 |
| HUIZENGA THEODORE ALAN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 28, 2025 |
| HARRIS ERIK Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 28, 2025 |
| HORN HOWARD Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 28, 2025 |
| HUANG DENNIS KARL Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 28, 2025 |
| PINION JOHN RICHARD Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 28, 2025 |
| CROMBEZ ERIC M.D. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 28, 2025 |
| PARSCHAUER KARAH HERDMAN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 28, 2025 |
| PARSCHAUER KARAH HERDMAN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 28, 2025 |
| KAKKIS EMIL D Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 28, 2025 |
| KASSBERG THOMAS RICHARD Chairman of the Board | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 28, 2025 |
| PARSCHAUER KARAH HERDMAN Officer | Sale at price 42.75 - 42.93 per share. | Direct | 128,224 | Feb 27, 2025 |
| KAKKIS EMIL D Chief Executive Officer | Sale at price 42.23 per share. | Indirect | 495,231 | Dec 30, 2024 |
| HUIZENGA THEODORE ALAN Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Dec 10, 2024 |
| KAKKIS EMIL D Chief Executive Officer | Sale at price 50.00 per share. | Indirect | 413,650 | Dec 10, 2024 |
| KAKKIS EMIL D Chief Executive Officer | Stock Gift at price 0.00 per share. | Indirect | 0 | Dec 9, 2024 |
| HORN HOWARD Chief Financial Officer | Sale at price 52.76 per share. | Direct | 393,853 | Oct 10, 2024 |
| HUIZENGA THEODORE ALAN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 16, 2024 |
| HUIZENGA THEODORE ALAN Officer | Sale at price 56.19 per share. | Direct | 5,113 | Sep 3, 2024 |
| KAKKIS EMIL D Chief Executive Officer | Sale at price 55.85 per share. | Indirect | 1,117,000 | Sep 3, 2024 |
| KAKKIS EMIL D Chief Executive Officer | Sale at price 50.17 per share. | Indirect | 1,003,400 | Aug 6, 2024 |
| SANDERS CORAZON CORSEE D Director | Sale at price 40.98 per share. | Direct | 23,932 | Jul 2, 2024 |
| DUNSIRE DEBORAH Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 18, 2024 |
| NARACHI MICHAEL A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 18, 2024 |
| SULIMAN SHEHNAAZ Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 18, 2024 |
| SANDERS CORAZON CORSEE D Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 18, 2024 |
| RAY AMRIT Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 18, 2024 |
| FUST MATTHEW K. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 18, 2024 |
| WELCH DANIEL G Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 18, 2024 |
| PARSCHAUER KARAH HERDMAN Officer | Sale at price 45.00 per share. | Direct | 441,270 | Jun 12, 2024 |
| SANDERS CORAZON CORSEE D Director | Sale at price 41.10 per share. | Direct | 71,391 | Jun 10, 2024 |
| CROMBEZ ERIC M.D. Officer | Sale at price 43.66 per share. | Direct | 15,456 | May 2, 2024 |
| CROMBEZ ERIC M.D. Officer | Sale at price 44.10 per share. | Direct | 6,262 | Apr 18, 2024 |
| KASSBERG THOMAS RICHARD Chairman of the Board | Sale at price 49.93 per share. | Direct | 574,644 | Mar 11, 2024 |
| FUST MATTHEW K. Director | Sale at price 50.85 - 50.89 per share. | Direct | 620,443 | Mar 7, 2024 |
Related Tickers
AGIO Agios Pharmaceuticals, Inc.
32.09
+0.79%
MREO Mereo BioPharma Group plc
2.1500
-2.71%
PTCT PTC Therapeutics, Inc.
48.52
-0.76%
FOLD Amicus Therapeutics, Inc.
6.07
-2.25%
BPMC Blueprint Medicines Corporation
101.35
-1.66%
APLS Apellis Pharmaceuticals, Inc.
16.93
-2.76%
IONS Ionis Pharmaceuticals, Inc.
33.51
+0.15%
CRNX Crinetics Pharmaceuticals, Inc.
30.51
-0.03%
SRRK Scholar Rock Holding Corporation
29.01
-2.78%
TVTX Travere Therapeutics, Inc.
15.02
-2.34%